Travere Therapeutics Inc. (TVTX)

TVTX trades at $25, 42.9% above the near-term max pain of $17.5 expiring Sep 19, 2025 (7 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($15-$20), reflecting growing call interest at higher strikes. Key magnetic zone at 15 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for TVTX shows an upward trend from 15 to 20, suggesting bullish positioning in longer-dated options. The 29% spread signals divergent expectations across timeframes. Most levels below 25 may cap rallies. Strong magnetic level at 15 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.